Asthmolysin

Pharmacology, Internal Medicine

Also known as: Asthmolysine

Historical document, translated for reference. It reflects medical knowledge of the 1920s–30s and is not medical advice.

Summary

Asthmolysin is a pharmaceutical preparation consisting of a mixture of adrenaline and pituitrin. It was introduced in 1912 by O. Weiss for the treatment of bronchial asthma, with the pituitrin acting to sensitize the sympathicotropic effect of the adrenaline.

Encyclopedia entry (1928–1936)

ASTHMOLYSIN, a mixture of 0.0008 adrenaline with 0.04 pituitrin, has been successfully used since 1912 by O. Weiss for the treatment of bronchial asthma; pituitrin sensitizes the sympathicotropic action of adrenaline. It is administered subcutaneously in doses of 0.5–1.0 of Asthmolysin, no more than once a day. Asthmolysin is dispensed in ampoules.

Mentioned in

Cite this page

“Asthmolysin.” Soviet Medical Encyclopedia. English translation of Bolshaya Meditsinskaya Entsiklopediya, 1st ed. (Moscow, 1928–1936), ed. N. A. Semashko. https://sovietmedicalencyclopedia.pages.dev/article/asthmolysin/